Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.
Risankizumab Efficacious in Patients with Prior Plaque Psoriasis Biologic Use
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
Phase 3 Data for Bimekizumab Shows Well Maintained Response
2 Clarke Drive Cranbury, NJ 08512